• Users Online: 185
  • Print this page
  • Email this page
Year : 2018  |  Volume : 1  |  Issue : 3  |  Page : 97-103

Ongoing evolution of response assessment in glioma: Where do we stand?

1 Department of Neurosurgery, Tianjin Medical University General Hospital; Laboratory of Neuro-Oncology, Tianjin Neurological Institute, Tianjin, China
2 Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China

Correspondence Address:
Dr. Xuejun Yang
154 An-shan Road, Tianjin 300052
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/glioma.glioma_13_18

Rights and Permissions

The investigation and development of recently introduced agents or radiological measurements caused emergent misunderstandings to the response assessment of glioma. To date, the classical Macdonald criteria and the response assessment of neuro-oncology (RANO) criteria have been used successively for the evaluation of glioma outcome. However, ongoing efforts on complementary assessments are necessary to combat this malignancy. In this review, we highlight the shortcomings of the current criteria and introduce the initiative effort of RANO guideline and its offspring. We also discuss some future barriers for accurate assessment of treatment response in glioma.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded559    
    Comments [Add]    
    Cited by others 2    

Recommend this journal